Adam Adler
Chief Scientific Officer
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Adam Adler is the Chief Scientific Officer at GigaGen in the United States. His research areas focus on antibody engineering, including the prediction of antibody binders and synthetic antibody generation through deep learning techniques. He has contributed to key studies in GMP manufacturing, recombinant hyperimmune globulin targeting SARS-CoV-2, and the effects of PD-L1/TGF-β blockade in the tumor microenvironment. His recent work includes advancements in single-cell transcriptomics and affinity maturation of antibodies.
Articles (5)
Year:
2022
Year:
2022
Year:
2021
Year:
2020
Year:
2020
Collaborators (1)
Andreu Garcia-Vilanova
Texas Biomedical Research Institute
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.